Mirae Asset Global Investments Co., Ltd. Silence Therapeutics PLC Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,817 shares of SLN stock, worth $11,174. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,817
Previous 1,573
15.51%
Holding current value
$11,174
Previous $4,000
150.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SLN
# of Institutions
57Shares Held
20.6MCall Options Held
22.8KPut Options Held
0-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$18.7 Million3.59% of portfolio
-
Siren, L.L.C. New York, NY2.91MShares$17.9 Million0.87% of portfolio
-
Redmile Group, LLC San Francisco, CA2.16MShares$13.3 Million1.53% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.85MShares$11.4 Million0.9% of portfolio
-
Morgan Stanley New York, NY1.21MShares$7.45 Million0.0% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $221M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...